|Front Page Next Story||
Four NIH'ers Named to Academies' IOM
Four NIH'ers are among 65 new members of the Institute of Medicine of the National Academies. IOM's total active membership now stands at 1,416.
Recently named members who work at NIH include Dr. Ezekiel J. Emanuel, chair, Clinical Center department of clinical bioethics; Dr. Alan E. Guttmacher, deputy director, National Human Genome Research Institute; Dr. Robert L. Nussbaum, chief, Genetic Disease Research Branch, NHGRI; and Dr. Thomas C. Quinn, senior investigator and section head, international AIDS/STDs, National Institute of Allergy and Infectious Diseases, and professor of medicine and deputy director, division of infectious diseases, Johns Hopkins University.
Established in 1970 by the National Academy of Sciences, IOM has become recognized as a national resource for independent, scientifically informed analysis and recommendations on issues related to human health. With election, members make a commitment to devote a significant amount of volunteer time as members of IOM committees, which engage in a broad range of studies on health policy issues.
NIGMS's Shapiro HonoredDr. Bert Shapiro, chief of the Cell Biology Branch in the NIGMS Division of Cell Biology and Biophysics, received an inaugural award from the M.D./Ph.D. Directors Association. Shapiro, who has administered the institute's Medical Scientist Training Program for the past 12 years, was recognized for his "diligent, persistent and exemplary efforts to improve the training of tomorrow's physician-scientists." The M.D./Ph.D. Directors Association facilitates communication among M.D.-Ph.D. programs on issues including admissions, recruitment, curriculum, advising and career opportunities. Shapiro received the honor at the association's recent annual conference in Keystone, Colo.
NEI Researchers Receive Award of Merit
For exceptional design and scientific administration of major collaborative clinical trials at NEI, Dr. Frederick L. Ferris III and Dr. Emily Y. Chew are co-recipients of the 2004 Award of Merit in Retina Research from the Retinal Research Foundation. Ferris is NEI clinical director and director of the institute's Division of Epidemiology and Clinical Research (DECR). Chew is DECR deputy director.
During his more than three decades at NEI, Ferris has been well known for his outstanding skills and experience in clinical trials. Chew has an international reputation for excellence in both clinical research and academic ophthalmology.
Among their many recent achievements was leadership of the groundbreaking Age-Related Eye Disease Study of more than 4,700 participants, 55-80 years of age, in 11 clinical centers nationwide, with varying stages of age-related macular degeneration (AMD) and cataracts. A significant finding of the study was that people at high risk of developing advanced stages of AMD lowered their risk by about 25 percent when treated with a high-dose formulation of antioxidant vitamins and zinc.
As award co-recipients, Chew and Ferris shared the honor of presenting the Charles L. Schepens Lecture at the annual Retina Society meeting, held in Baltimore.
Up to Top